​

Funding Round

Private Equity Round - Y-mAbs Therapeutics

Private Equity Round - Y-mAbs Therapeutics

Investment Firm

Overview

YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.

Announced Date

Nov 29, 2017

Funding Type

Private Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Scopia Capital

Scopia Capital

Scopia Capital is a private_equity firm.

Participant Investors

3

Investor Name
Participant InvestorScopia Capital
Participant InvestorHBM Healthcare Investments
Participant InvestorSofinnova Investments

Round Details and Background

Y-mAbs Therapeutics raised $30000000 on 2017-11-29 in Private Equity Round

YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 29, 2017
Private Equity Round - Y-mAbs Therapeutics
3-30.0M
Feb 17, 2021
Post-IPO Equity - Y-mAbs Therapeutics
-115.0M
Oct 29, 2019
Post-IPO Equity - Y-mAbs Therapeutics
-143.8M
Oct 24, 2017
Private Equity Round - Y-mAbs Therapeutics
1-50.0M

Recent Activity

There is no recent news or activity for this profile.